| 08.30 - 10.00 |
Thang Long Ballroom |
| Plenary Session 3: Developments in Clinical Transfusion Medicine |
| Chair: Chairs: Erhard Seifried, Bach Quoc Khanh |
| 08.30 - 09.15 |
| 3A-PL3-1 |
IMPLEMENTATION OF TRANSFUSION PRACTICE |
| |
P. Flanagan (New Zealand Blood Service, Auckland, New Zealand) |
| 09.15 - 10.00 |
| 2A-PL1-2 |
CELLULAR AND TISSUE THERAPIES: THE ROLE OF TRANSFUSION MEDICINE |
| |
M. Strong, K Loper (Puget Sound Blood Center, Seattle, WA, USA) |
| |
| 10.00 - 10.30 |
| COFFEE BREAK |
| |
| 10.30 - 12.00 |
Function Room 6/7 |
| Simultaneous Session 7: Models of Increased Safety Measurers |
| Chairs: Jean Pierre Allain, Pham Quang Vinh |
| 10.30 - 10.50 |
| 3B-S07-1 |
PATHOGEN INACTIVATION OF LABILE BLOOD PRODUCTS IN 2007 |
| |
J.P. Cazenave (EFS-Alsace, Strasbourg, France) |
| 10.50 - 11.10 |
| 3B-S07-2 |
REPORT OF THE CANADIAN CONSENSUS CONFERENCE ON PATHOGEN INACTIVATION |
| |
F. Décary (Héma-Québec, Quebec, Canada) |
| 11.10 - 11.30 |
| 3B-S07-3 |
RISK ASSESSMENT: A NEW PLAYING FIELD |
| |
M.P. Janssen, C.L. Van der Poel (UMC Utrecht, Utrecht, The Netherlands) |
| 11.30 - 11.45 |
| 3B-S07-4 |
INFLUENCE OF RIBOFLAVIN PHOTOINACTIVATION TREATMENT ON COAGULATION FACTORS FROM FRESH FROZEN PLASMA |
| |
L. Larrea, M. Calabuig, J. Rivera, V. Vicente, R. Roig (Centro Transfusion Comunidad Valenciana, Valencia, Spain) |
| 11.45 - 12.00 |
| 3B-S07-5 |
POTASSIUM EFFLUX AND RED CELL HEMOLYSIS AFTER GAMMA IRRADIATION: CORRELATION WITH STORAGE AND TIMING OF GAMMA IRRADIATION |
| |
R. Sawant, P. Nagaraju, S. Kannan, A. Marathe, S. Rajadhyaksha (Actrec-Tata Memorial Centre, Navi Mumbai, India) |
| |
| 10.30 - 12.00 |
Function Room 1/2 |
| Simultaneous Session 8: Expanding the Role of Blood Banks/Hospitals |
| Chairs: Parick Coghlan, Nguyen Tan Binh |
| 10.30 - 10.50 |
| 3B-S08-1 |
EXPANDING THE ROLE OF HOSPITAL BLOOD BANKS |
| |
J.C. Faber (Luxembourg Red Cross, Luxembourg, Luxembourg) |
| 10.50 - 11.10 |
| 3B-S08-2 |
HOSPITAL TRANSFUSION COMMITTEE |
| |
P. Ouellet (CHUQ, Québec City, Canada) |
| 11.10 - 11.30 |
| 3B-S08-3 |
RECENT DEVELOPMENTS IN BLOOD SAVING TECHNIQUES |
| |
D. Thomas (Swansea NHS Trust, Swansea, United Kingdom) |
| 11.30 - 11.45 |
| 3B-S08-4 |
IMPORTENCE OF IMPLEMENTING A MSBOS IN A HOSPITAL |
| |
T.G.D. Liyanage (Sri Jayawardenapura General Hospital, Rajagiriya, Sri Lanka) |
| 11.45 - 12.00 |
| 3B-S08-5 |
BLOOD SAFETY AND HOSPITAL BLOOD BANKS |
| |
S. Zolfaghari Anaraki, A. Talebian, M. Sarmadi, G. Heydari Rad, S. Sedaghat Rad, N. Hasanpoor (Iranian Blood Transfusion Research Cente, Tehran, Iran) |
| |
| 10.30 - 12.00 |
Thang Long Ballroom |
| Simultaneous Session 9: Platelets Transfusion |
| Chairs: Cécile Kaplan, Duong Ba Truc |
| 10.30 - 10.50 |
| 3B-S09-1 |
CURRENT STATUS OF PLATELET TRANFUSION IN JAPAN |
| |
S. Takamoto (Aichi Medical University, Aichi, Japan) |
| 10.50 - 11.10 |
| 3B-S09-2 |
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: WHERE DO WE STAND? |
| |
C. Kaplan (G.I.P. - I.N.T.S., Paris, France) |
| 11.10 - 11.30 |
| 3B-S09-3 |
FIVE HUMAN PLATELET ANTIGEN SYSTEMS STUDIED IN THE KINH VIETNAMESE POPLULATION |
| |
K. Bach, L. Halle, C. Martageix, F. Bianchi, T. Le T Kim, M.C. Morel-Kopp, C. Kaplan, M. Nguyen Ngoc, H. Nguyen Ngoc (NIHBT, Hanoi, Vietnam) |
| 11.30 - 11.45 |
| 3B-S09-4 |
EXPERIENCE OF SINGLE DONOR PLATELET APHERESIS PROCEDURES ON DIFFERENT CELL SEPARATOR MACHINES: COMPARISON OF THE PLATELET YIELD, COLLECTION EFFICIENCY AND DONOR COMFORT |
| |
D. Sen, A. Khetarpal, S. Jetley (Armed Forces Transfusion Centre, New Delhi, India) |
| 11.45 - 12.00 |
| 3B-S09-5 |
SEMI-AUTOMAT PRODUCTION OF POOLED PLATELETS IN SSP+ FOR 7-DAYS STORAGE |
| |
W. Nussbaumer, I. Springer, B. Fidahic, M. Horngacher, H. Schennach, E.M. Amann, W. Mayr (Univ.-Hospital Innsbruck, Innsbruck, Austria) |
| |
| 12.00 - 14.00 |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS |
| 14.00 - 15.30 |
Function Room 6/7 |
| Simultaneous Session 10: Blood Donor Recruitment |
| Chairs: Diane De Coning, Nguyen Chi Tuyen |
| 14.00 - 14.20 |
| 3B-S10-1 |
ESTABLISHMENT OF A STABLE BASE OF VNRBD IN VIETNAM |
| |
N.M.Q. Ngo, Duc Thuan Nguyen, Anh Tri Nguyen (National Inst. of Hematology & BT, Ha Noi, Vietnam) |
| 14.20 - 14.40 |
| 3B-S10-2 |
PROMOTION ACTIVITIES IN BLOOD DONATION |
| |
N.M. Mikkelsen (IFBDO/FIODS, Frederiksberg, Denmark) |
| 14.40 - 15.00 |
| 3B-S10-3 |
THE CRITICAL ROLE OF VOLUNTEERS IN THE SUCCESS OF BLOOD DRIVES |
| |
R.M. Bindusara (NBTS Central Blood Bank, Colombo, Sri Lanka) |
| 15.00 - 15.15 |
| 3B-S10-4 |
THE REASONS FOR DEFERRAL OF VOLUNTARY BLOOD DONORS IN THE PERIOD FROM 2002 TO 2006 |
| |
V. Urlep Salinovic, L. Lokar, I. Maracic, I. Maracic (Teaching Hospital, Maribor, Slovenia) |
| 15.15 - 15.30 |
| 3B-S10-5 |
DEMOGRAPHIC PATTERN OF NEW BLOOD DONORS COMPARED TO REGULAR BLOOD DONORS IN NORTHEN REGIONAL TRANSFUSION CENTRE, ALOR STAR, MALAYSIA FOR 2006 |
| |
N. Hashim, P.L. Khoo, A.R. Mohd Ibrahim (Hospital Alor Setar, Alor Setar, Malaysia) |
| |
| 14.00 - 15.30 |
Thang Long Ballroom |
| Simultaneous Session 11: Transfusion Practice in Specific Clinical Situations |
| Chair: Duong Ba Truc |
| 14.00 - 14.20 |
| 3B-S11-1 |
MASSIVE TRANSFUSION IN TRAUMA PATIENTS |
| |
S. Huber-Wagner (University Hospital of Munich - LMU, Munich, Germany) |
| 14.20 - 14.40 |
| 3B-S11-2 |
THALASSEMIC MANAGEMENT IN HONG KONG |
| |
R. Liang, W.Y. Au (The University of Hong Kong, Hong Kong, China) |
| 14.40 - 15.00 |
| 3B-S11-3 |
DENGUE FEVER PREVENTION AND TREATMENT |
| |
N.D. Hien (National Hospital of Tropical Diseases, Hanoi, Vietnam) |
| 15.00 - 15.15 |
| 3B-S11-4 |
EFFECT OF ANTIFIBRINOLYTIC DRUGS ON TRANSFUSION REQUIREMENT AND BLOOD LOSS DURING ORTHOTOPIC LIVER TRANSPLANTATION: RESULTS FROM A SINGLE CENTER |
| |
A. Allanki (Global Hospital, Hyderabad, India) |
| 15.15 - 15.30 |
| 3B-S11-5 |
THERAPEUTIC APHERESIS IN MANTLE CELL LYMPHOMA IN LEUKAEMIC PHASE: A CASE REPORT |
| |
D. Nguyen, P. La Rosee, Th. Nebe, D. Buchheidt, H. Klüter (Med.Faculty Mannheim, Univ.Heidelberg, Mannheim, Germany) |
| |
| 14.00 - 15.30 |
Function Room 1/2 |
| Simultaneous Session 12: Safety of Cells and Tissues and Its Donors |
| Chairs: Martin Olsson, Nguyen Thi Thu Ha |
| 14.00 - 14.20 |
| 3B-S12-1 |
CORD BLOOD BANK |
| |
T.A. Takahashi (The Institute of Medical Science / The University of Tokyo, Tokyo, Japan) |
| 14.20 - 14.40 |
| 3B-S12-2 |
REGULATION OF TISSUES AND CELLS |
| |
A. Farrugia (Therapeutic Goods Admin. Labs., Woden, Act, Australia) |
| 14.40 - 15.00 |
| 3B-S12-3 |
MOBILISATION AND SAFETY OF G-CSF MOBILIZED STEM CELL DONATION |
| |
A. Brand, J. Wiersum-Osselton van, A. Walraven, W.E. Fibbe (Sanquin Blood Supply, Leiden, The Netherlands) |
| 15.00 - 15.15 |
| 3B-S12-4 |
STORAGE COMPARISON OF CORD BLOOD AND DONATED BLOOD |
| |
N. Solaz, S. Tokan, A. Avci, S. Elgun, E. Gulyapar, Z. Ustunyurt, Z. Biyikci, A. Kemahli (Ankara University, Ankara, Turkey) |
| 15.15 - 15.30 |
| 3B-S12-5 |
STUDY ON CITRATE EFFECTS IN PLATELETPHERESIS DONORS |
| |
Y.R. Ko, S.L. Loh, R. Noorhayati, K.J. Foo, C.L. Toh, H.H. Tan, D. Teo (Health Sciences Authority, Singapore, Singapore) |
| |
| 15.30 - 16.00 |
| TEA BREAK |
| |
| 16.00 - 17.30 |
Function Room 1/2 |
| Simultaneous Session 13: Haemovigilance in Patients |
| Chairs: Pierre Robillard, Tran Van Binh |
| 16.00 - 16.20 |
| 3B-S13-1 |
HAEMOVIGILANCE IN NEW ZEALAND |
| |
P. Flanagan (New Zealand Blood Service, Auckland, New Zealand) |
| 16.20 - 16.40 |
| 3B-S13-2 |
TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE (T-A G-V-H D) |
| |
P.V. Holland (UC Davis Medical Center, Sacramento, USA) |
| 16.40 - 17.00 |
| 3B-S13-3 |
THE BENEFITS OF THE JAPANESE HAEMOVIGILANCE SYSTEM FOR BETTER PATIENT CARE |
| |
H. Okazaki (Japanese Red Cross Society, Tokyo, Japan) |
| 17.00 - 17.15 |
| 3B-S13-4 |
DETECTION OF HPDEL AMONG THAIS, DELETED ALLELE OF HAPTOGLOBIN GENE THAT CAUSES CONGENITAL HAPTOGLOBIN DEFICIENCY |
| |
E. Shimada, M. Odagiri, K. Chaiwong, Y. Watanabe, M. Anazawa, T. Mazda, H. Okazaki, T. Juji, R. O’Charoen, K. Tadokoro (The Japanese Red Cross, Tokyo, Japan) |
| 17.15 - 17.30 |
| 3B-S13-5 |
STRENGTH OF HLA ANTIBODY WITH POSITIVE CROSS MATCH TEST IN THE DONORS OF TRALI |
| |
S. Hashimoto, F. Nakajima, H. Kamada, K. Kawamura, H. Okazaki, K. Tadokoro (Japanese Red Cross Society, Tokyo, Japan) |
| |
| 16.00 - 17.30 |
Function Room 6/7 |
| Simultaneous Session 14: Potentials for Plasma Derived or Recombinant Protein Products |
| Chairs: Albert Farrugia, Nguyen Thi Nga |
| 16.00 - 16.20 |
| 3B-S14-1 |
THE AUSTRALASIAN REGISTRY OF FVIIA |
| |
J. Isbister (University of Sydney / Royal North Shore Hospital of Sydney, Petersham, Australia) |
| 16.20 - 16.40 |
| 3B-S14-2 |
USE AND MIS-USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE WORLD |
| |
P.F.W. Strengers (Sanquin, Amsterdam, The Netherlands) |
| 16.40 - 17.00 |
| 3B-S14-3 |
WHO RECOMMENDATIONS ON THE PRODUCTION, CONTROL AND REGULATION OF PLASMA FOR FRACTIONATION |
| |
A.P. Padilla (WHO, Geneva, Switzerland) |
| 17.00 - 17.15 |
| 3B-S14-4 |
A NOVEL DELIVERY SYSTEM TO CONSERVE IVIG IN THE TREATMENT OF AUTOIMMUNITY? |
| |
H. Lazarus, V. Siragam, R. Crow (Canadian Blood Services, Toronto, Canada) |
| 17.15 - 17.30 |
| 3B-S14-5 |
ISOLATION, CLONING, EXPRESSION AND PURIFICATION OF RECOMBINANT RHD ANTIGEN FROM CORD BLOOD |
| |
M. Habibi Roudkenar, O. Oodi, H. Halabian, N. Amirizadeh, E. Kamali, H. Rezvan (Iranian Blood Transfusion Organization, Tehran, Iran) |
| |
| 16.00 - 17.30 |
Thang Long Ballroom |
| Simultaneous Session 15: Quality Management |
| Chairs: Jean Claude Faber, Pham Tuan Duong |
| 16.00 - 16.20 |
| 3B-S15-1 |
ISBT 128 - CONTRIBUTING TO THE SAFETY OF TRANSFUSION AND TRANSPLANTATION |
| |
P. Ashford (ICCBBA, Bridgend, United Kingdom) |
| 16.20 - 16.40 |
| 3B-S15-2 |
INFORMATION AND TRACEBILITY IN TRANSFUSION MEDICINE |
| |
F. Décary (Héma-Québec, Quebec, Canada) |
| 16.40 - 17.00 |
| 3B-S15-3 |
QUALITY MANAGEMENT IN THE BLOOD BANK / HOSPITAL |
| |
V.A. Armstrong (Australian Red Cross Blood Service, Perth, Australia) |
| 17.00 - 17.15 |
| 3B-S15-4 |
IMPLEMENTATION OF ISBT 128 AT CENTRE FOR TRANSFUSION MEDICINE, SINGAPORE |
| |
K.Q. Ng (Centre for Transfusion Medicine, Singapore, Singapore) |
| 17.15 - 17.30 |
| 3B-S15-5 |
PRELIMINARY STUDY FOR THE PRODUCTION OF A KOREAN HBSAG NATIONAL STANDARD |
| |
N.S. Cho, K.W. Youn, Y.J. Cho, K.Y. Choi, S.Y. Kwon, M.W. Hwang, J.H. Lee, S.W. Ryu, G.W. Ha (Blood Transfusion Research Institute, Seoul, South-Korea) |
